Vanguard Personalized Indexing Management’s Cogent Biosciences COGT Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$326K	Buy	+8,459	New	+$312K	﹤0.01%	1568

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Personalized Indexing Management's COGT Position: Q1 2026 in Review

Vanguard Personalized Indexing Management opened a new position in Cogent Biosciences (COGT) in Q1 2026: 8,459 shares worth $326K. The stake represents ﹤0.01% of the portfolio and ranks #1568 among its holdings.

305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Vanguard Personalized Indexing Management held 8,459 shares of Cogent Biosciences worth $326K as of Q1 2026.
Cogent Biosciences was a new Vanguard Personalized Indexing Management position in Q1 2026.
Cogent Biosciences made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1568 holding.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.